Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors.
Berger R, Fiegl H, Goebel G, Obexer P, Ausserlechner M, Doppler W, Hauser-Kronberger C, Reitsamer R, Egle D, Reimer D, Müller-Holzner E, Jones A, Widschwendter M. Berger R, et al. Among authors: widschwendter m. Cancer Sci. 2010 Apr;101(4):1059-66. doi: 10.1111/j.1349-7006.2010.01491.x. Epub 2010 Jan 12. Cancer Sci. 2010. PMID: 20156214 Free PMC article.
Effects of Taxol on choriocarcinoma cells.
Marth C, Lang T, Widschwendter M, Müller-Holzner E, Daxenbichler G. Marth C, et al. Among authors: widschwendter m. Am J Obstet Gynecol. 1995 Dec;173(6):1835-42. doi: 10.1016/0002-9378(95)90437-9. Am J Obstet Gynecol. 1995. PMID: 8610772
Activity of retinoic acid receptor-gamma selectively binding retinoids alone and in combination with interferon-gamma in breast cancer cell lines.
Widschwendter M, Daxenbichler G, Culig Z, Michel S, Zeimet AG, Mörtl MG, Widschwendter A, Marth C. Widschwendter M, et al. Among authors: widschwendter a. Int J Cancer. 1997 May 2;71(3):497-504. doi: 10.1002/(sici)1097-0215(19970502)71:3<497::aid-ijc31>3.0.co;2-a. Int J Cancer. 1997. PMID: 9139890 Free article.
Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer.
Zeimet AG, Widschwendter M, Knabbe C, Fuchs D, Herold M, Müller-Holzner E, Daxenbichler G, Offner FA, Dapunt O, Marth C. Zeimet AG, et al. Among authors: widschwendter m. J Clin Oncol. 1998 May;16(5):1861-8. doi: 10.1200/JCO.1998.16.5.1861. J Clin Oncol. 1998. PMID: 9586902
225 results